Endocrine system - commissioning policies
Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here

The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Alogliptin (Vipidia®) tablets for the treatment of type 2 diabetesClick here to download this file
Add this document to cartDulaglutide (Trulicity®) for the treatment of type 2 diabetesClick here to download this file
Add this document to cartInsulin Degludec 100units/ml (Tresiba®) for Type 1 Diabetes Click here to download this file
Add this document to cartInsulin Degludec for Type 2 DiabetesClick here to download this file
Add this document to cartLixisenatide for type 2 diabetesClick here to download this file
Add this document to cart
Please note:  Some commissioning policies approved by the previous commissioning organisations are yet to be reviewed and updated. There is an on-going programme of work in place to review and update these policies. They will then be published under the appropriate category. 

In the meantime they are still applicable to Northern, Eastern and Western Devon CCG. Former NHS Devon policies can be accessed here
Rate this Page.
Great
Okay
Bad